2-Bromo-4,5-Dimethoxy Chalcone Inhibits Cisplatin-induced LLC-PK1 Kidney Cell Death
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Dahae | - |
dc.contributor.author | Lee, Heesu | - |
dc.contributor.author | Kang, Ki Sung | - |
dc.contributor.author | Lee, Jae Wook | - |
dc.date.available | 2020-02-27T10:42:35Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2018-05 | - |
dc.identifier.issn | 1229-5949 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3789 | - |
dc.description.abstract | The kidney has various functions, including modulating blood pressure, balancing electrolytes, and controlling blood volume. Among these functions, extracting metabolic waste from blood plays an important role in kidney. 1,2 Additionally, kidney epithelial cells are vulnerable to the toxic effects of various chemical agents and medications. 3,4 Recently, cisplatin, an inorganic platinum-based chemotherapeutic agent, has been used to inhibit solid malignant tumors due to its high therapeutic potential. 5,6 However, continuous exposure to cisplatin can cause various significant side effects, such as bone marrow suppression, peripheral neuropathy, and nephrotoxicity. In particular, a single dose of cisplatin treatment can cause nephrotoxicity among one-third of patients.(7-9) Therefore, it has been suggested to develop medication for cisplatin-induced nephrotoxicity. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.relation.isPartOf | BULLETIN OF THE KOREAN CHEMICAL SOCIETY | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | INDUCED CYTOTOXICITY | - |
dc.subject | TYROSINE KINASE | - |
dc.subject | AGENTS | - |
dc.subject | ANALOGS | - |
dc.subject | APOPTOSIS | - |
dc.subject | INJURY | - |
dc.subject | ISOLIQUIRITIGENIN | - |
dc.subject | PATHWAYS | - |
dc.subject | DESIGN | - |
dc.title | 2-Bromo-4,5-Dimethoxy Chalcone Inhibits Cisplatin-induced LLC-PK1 Kidney Cell Death | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000431622800022 | - |
dc.identifier.doi | 10.1002/bkcs.11454 | - |
dc.identifier.bibliographicCitation | BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.39, no.5, pp.699 - 702 | - |
dc.identifier.kciid | ART002345475 | - |
dc.identifier.scopusid | 2-s2.0-85045315288 | - |
dc.citation.endPage | 702 | - |
dc.citation.startPage | 699 | - |
dc.citation.title | BULLETIN OF THE KOREAN CHEMICAL SOCIETY | - |
dc.citation.volume | 39 | - |
dc.citation.number | 5 | - |
dc.contributor.affiliatedAuthor | Kang, Ki Sung | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Chalcone | - |
dc.subject.keywordAuthor | Cisplatin | - |
dc.subject.keywordAuthor | Kidney cells | - |
dc.subject.keywordAuthor | Renoprotection | - |
dc.subject.keywordAuthor | MAPK pathway | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | INDUCED CYTOTOXICITY | - |
dc.subject.keywordPlus | TYROSINE KINASE | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordPlus | ANALOGS | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | INJURY | - |
dc.subject.keywordPlus | ISOLIQUIRITIGENIN | - |
dc.subject.keywordPlus | PATHWAYS | - |
dc.subject.keywordPlus | DESIGN | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.